Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BioXcel Therapeutics, Inc. | 17,000 | reported | 09 Jan 2026 | tx 28+790,749−69,417 |
| TERRAFORM GLOBAL, INC. | 0 | reported | 28 Dec 2017 | tx 4+67,500−67,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Jan 2026 | GRANT_AWARD | BioXcel Therapeutics, Inc. | 17,000 | 0.00 USD | deriv |
| 31 Oct 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 1,694 | — | |
| 31 Oct 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 1,694 | 0.00 USD | deriv |
| 30 Sept 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 1,694 | — | |
| 30 Sept 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 1,694 | 0.00 USD | deriv |
| 31 Aug 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 1,693 | — | |
| 31 Aug 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 1,693 | 0.00 USD | deriv |
| 31 Jul 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 1,693 | — | |
| 31 Jul 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 1,693 | 0.00 USD | deriv |
| 30 Jun 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 1,693 | — | |
| 30 Jun 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 1,693 | 0.00 USD | deriv |
| 31 May 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 1,693 | — | |
| 31 May 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 1,693 | 0.00 USD | deriv |
| 30 Apr 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 1,693 | — | |
| 30 Apr 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 1,693 | 0.00 USD | deriv |
| 31 Mar 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 1,693 | — | |
| 31 Mar 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 1,693 | 0.00 USD | deriv |
| 28 Feb 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 1,693 | — | |
| 28 Feb 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 1,693 | 0.00 USD | deriv |
| 31 Jan 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 27,089 | — | |
| 31 Jan 2025 | EXERCISE | BioXcel Therapeutics, Inc. | 27,089 | 0.00 USD | deriv |
| 31 Dec 2024 | EXERCISE | BioXcel Therapeutics, Inc. | 27,089 | — | |
| 31 Dec 2024 | EXERCISE | BioXcel Therapeutics, Inc. | 27,089 | 0.00 USD | deriv |
| 30 Nov 2024 | EXERCISE | BioXcel Therapeutics, Inc. | 27,089 | — | |
| 21 Nov 2024 | GRANT_AWARD | BioXcel Therapeutics, Inc. | 297,988 | 0.00 USD | deriv |